{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:08:26Z","timestamp":1777356506028,"version":"3.51.4"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1007\/s11926-002-0089-7","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T16:03:52Z","timestamp":1180800232000},"page":"434-441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Idiopathic inflammatory myopathy: Autoantibody update"],"prefix":"10.1007","volume":"4","author":[{"given":"Ira N.","family":"Targoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"89_CR1","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","volume":"70","author":"LA Love","year":"1991","unstructured":"Love LA, Leff RL, Fraser DD, et al.: A new approach to the classification of idiopathic inflammatory myopathy: myositisspecific autoantibodies define useful homogeneous patient groups. Medicine 1991, 70:360\u2013374.","journal-title":"Medicine"},{"key":"89_CR2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1172\/JCI114461","volume":"85","author":"FW Miller","year":"1990","unstructured":"Miller FW, Twitty SA, Biswas T, Plotz PH: Origin and regulation of a disease-specific autoantibody response: antigenic epitopes, spectrotype stability, and isotype restriction of anti- Jo-1 antibodies. J Clin Invest 1990, 85:468\u2013475.","journal-title":"J Clin Invest"},{"key":"89_CR3","doi-asserted-by":"publisher","first-page":"9933","DOI":"10.1073\/pnas.87.24.9933","volume":"87","author":"FW Miller","year":"1990","unstructured":"Miller FW, Waite KA, Biswas T, Plotz PH: The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity. Proc Natl Acad Sci U S A 1990, 87:9933\u20139937.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"89_CR4","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/art.1780350718","volume":"35","author":"IN Targoff","year":"1992","unstructured":"Targoff IN, Trieu EP, Plotz PH, Miller FW: Antibodies to glycyltransfer RNA synthetase in patients with myositis and interstitial lung disease. Arthritis Rheum 1992, 35:821\u2013830.","journal-title":"Arthritis Rheum"},{"key":"89_CR5","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1002\/art.1780390910","volume":"39","author":"FC Arnett","year":"1996","unstructured":"Arnett FC, Targoff IN, Mimori T, et al.: Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum 1996, 39:1507\u20131518.","journal-title":"Arthritis Rheum"},{"key":"89_CR6","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0889-857X(21)00070-3","volume":"20","author":"IN Targoff","year":"1994","unstructured":"Targoff IN: Immune manifestations of inflammatory muscle disease. Rheum Dis Clin North Am 1994, 20:857\u2013880.","journal-title":"Rheum Dis Clin North Am"},{"key":"89_CR7","first-page":"267","volume-title":"Diseases of Skeletal Muscle.","author":"IN Targoff","year":"2000","unstructured":"Targoff IN: Autoantibodies and muscle disease. In Diseases of Skeletal Muscle. Edited by Wortmann RL. Philadelphia: Lippincott Williams & Wilkins; 2000:267\u2013291."},{"key":"89_CR8","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/art.1780390424","volume":"39","author":"C Gelpi","year":"1996","unstructured":"Gelpi C, Kanterewicz E, Gratacos J, et al.: Coexistence of two antisynthetases in a patient with the antisynthetase syndrome. Arthritis Rheum 1996, 39:692\u2013697.","journal-title":"Arthritis Rheum"},{"key":"89_CR9","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/art.1780330908","volume":"33","author":"IN Targoff","year":"1990","unstructured":"Targoff IN, Johnson AE, Miller FW: Antibody to signal recognition particle in polymyositis. Arthritis Rheum 1990, 33:1361\u20131370.","journal-title":"Arthritis Rheum"},{"key":"89_CR10","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/art.1780390521","volume":"39","author":"R Mierau","year":"1996","unstructured":"Mierau R, Dick T, Bartz-Bazzanella P, et al.: Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR beta chain. Arthritis Rheum 1996, 39:868\u2013876.","journal-title":"Arthritis Rheum"},{"key":"89_CR11","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/art.1780351014","volume":"35","author":"CV Oddis","year":"1992","unstructured":"Oddis CV, Okano Y, Rudert WA, et al.: Serum autoantibody to the nucleolar antigen PM-Scl: clinical and immunogenetic associations. Arthritis Rheum 1992, 35:1211\u20131217.","journal-title":"Arthritis Rheum"},{"key":"89_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1046\/j.1365-2249.1997.4081308.x","volume":"109","author":"SA Rutjes","year":"1997","unstructured":"Rutjes SA, Vree Egberts WT, Jongen P, et al.: Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy. Clin Exp Immunol 1997, 109:32\u201340.","journal-title":"Clin Exp Immunol"},{"key":"89_CR13","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/1529-0131(199707)40:7<1257::AID-ART10>3.0.CO;2-R","volume":"40","author":"I Hausmanowa-Petrusewicz","year":"1997","unstructured":"Hausmanowa-Petrusewicz I, Kowalska-Oledzka E, Miller FW, et al.: Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum 1997, 40:1257\u20131266.","journal-title":"Arthritis Rheum"},{"key":"89_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1136\/ard.60.2.116","volume":"60","author":"R Brouwer","year":"2001","unstructured":"Brouwer R, Hengstman GJ, Vree E, et al.: Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 2001, 60:116\u2013123. This important multicenter study examined the frequency of myositis autoantibodies in a large number of European patients with myositis using sensitive techniques. Although trends were similar to previous studies, the study found a higher frequency of defined antibodies in inclusion body mysositis, of anti-Mi-2 in polymyositis, of anti-SRP in dermatomyositis, and of co-existence of myositis-associated autoantibodies, than previous studies.","journal-title":"Ann Rheum Dis"},{"key":"89_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/(SICI)1097-4598(199801)21:1<115::AID-MUS15>3.0.CO;2-2","volume":"21","author":"BM Koffman","year":"1998","unstructured":"Koffman BM, Rugiero M, Dalakas MC: Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis. Muscle Nerve 1998, 21:115\u2013117.","journal-title":"Muscle Nerve"},{"key":"89_CR16","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1136\/ard.60.8.810","volume":"60","author":"R Mierau","year":"2001","unstructured":"Mierau R, Dick T, Genth E: Less specific myositis autoantibodies? Ann Rheum Dis 2001, 60:810.","journal-title":"Ann Rheum Dis"},{"key":"89_CR17","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/qjmed\/77.1.1019","volume":"77","author":"C Marguerie","year":"1990","unstructured":"Marguerie C, Bunn CC, Beynon HLC, et al.: Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 1990, 77:1019\u20131038.","journal-title":"Q J Med"},{"key":"89_CR18","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/jnnp.70.5.706","volume":"70","author":"GJ Hengstman","year":"2001","unstructured":"Hengstman GJ, ter Laak HJ, van Engelen BG, van Venrooij BG: Anti-Jo-1 positive inclusion body myositis with a marked and sustained clinical improvement after oral prednisone. J Neurol Neurosurg Psychiatry 2001, 70:706. An interesting case that provides insight into the potential significance of anti-Jo-1 occurring in patients with inclusion body mysositis.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"89_CR19","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/art.1780390218","volume":"39","author":"D Vazquez-Abad","year":"1996","unstructured":"Vazquez-Abad D, Rothfield NF: Sensitivity and specificity of anti-Jo-1 antibodies in autoimmune diseases with myositis. Arthritis Rheum 1996, 39:292\u2013296.","journal-title":"Arthritis Rheum"},{"key":"89_CR20","doi-asserted-by":"publisher","first-page":"S378","DOI":"10.1002\/1529-0131(200002)43:2<378::AID-ANR18>3.0.CO;2-2","volume":"43","author":"M Hirakata","year":"2000","unstructured":"Hirakata M, Suwa A, Satoh S, et al.: Clinical features of Japanese patients with anti-aminoacyl tRNA synthetase autoantibodies: the immunogenetic backgrounds [abstract]. Arthritis Rheum 2000, 43:S378.","journal-title":"Arthritis Rheum"},{"key":"89_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0002-9343(90)90149-8","volume":"88","author":"IN Targoff","year":"1990","unstructured":"Targoff IN, Arnett FC: Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am J Med 1990, 88:241\u2013251.","journal-title":"Am J Med"},{"key":"89_CR22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0049-0172(96)80026-6","volume":"26","author":"AW Friedman","year":"1996","unstructured":"Friedman AW, Targoff IN, Arnett FC: Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum 1996, 26:459\u2013467.","journal-title":"Semin Arthritis Rheum"},{"key":"89_CR23","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.4049\/jimmunol.162.4.2315","volume":"162","author":"M Hirakata","year":"1999","unstructured":"Hirakata M, Suwa A, Nagai S, et al.: Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol 1999, 162:2315\u20132320. This report describes the most recently identified anti-synthetase. The antibody immunoprecipitates a distinctive tranfer-ribonucleic-acid and specifically inhibits the function of the enzyme. It was found in association with lung disease but not myositis.","journal-title":"J Immunol"},{"key":"89_CR24","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/00002281-200011000-00005","volume":"12","author":"M Hirakata","year":"2000","unstructured":"Hirakata M, Nagai S: Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol 2000, 12:501\u2013508.","journal-title":"Curr Opin Rheumatol"},{"key":"89_CR25","first-page":"1336","volume":"25","author":"I Marie","year":"1998","unstructured":"Marie I, Hatron PY, Hachulla E, et al.: Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol 1998, 25:1336\u20131343.","journal-title":"J Rheumatol"},{"key":"89_CR26","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/art.1780381020","volume":"38","author":"K Clawson","year":"1995","unstructured":"Clawson K, Oddis CV: Adult respiratory distress syndrome in polymyositis patients with the anti-Jo-1 antibody. Arthritis Rheum 1995, 38:1519\u20131523.","journal-title":"Arthritis Rheum"},{"key":"89_CR27","first-page":"728","volume":"112","author":"M Tomsic","year":"2000","unstructured":"Tomsic M, Sifrer F: Acute respiratory distress syndrome in a polymyositis patient with the anti-Jo-1 antibody. Wiener Klinische Wochenschrift 2000, 112:728\u2013731.","journal-title":"Wiener Klinische Wochenschrift"},{"key":"89_CR28","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1164\/ajrccm.164.7.2103110","volume":"164","author":"WW Douglas","year":"2001","unstructured":"Douglas WW, Tazelaar HD, Hartman TE, et al.: Polymyositisdermatomyositis- associated interstitial lung disease. Am J Respir Crit Care Med 2001, 164:1182\u20131185. Reviewing The Mayo Clinic experience with this condition, this study suggests that the majority of patients with interstitial lung disease in myositis have non-specific interstitial pneumonia and a better prognosis than idiopathic pulmonary fibrosis.","journal-title":"Am J Respir Crit Care Med"},{"key":"89_CR29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/cdli.4.2.236-240.1997","volume":"4","author":"M Kalenian","year":"1997","unstructured":"Kalenian M, Zweiman B: Inflammatory myopathy, bronchiolitis obliterans\/organizing pneumonia, and anti-Jo-1 antibodies: an interesting association. Clin Diagn Lab Immunol 1997, 4:236\u2013240.","journal-title":"Clin Diagn Lab Immunol"},{"key":"89_CR30","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1002\/art.1780331106","volume":"33","author":"CV Oddis","year":"1990","unstructured":"Oddis CV, Medsger TA Jr, Cooperstein LA: A subluxing arthropathy associated with the anti-Jo-1 antibody in polymyositis\/ dermatomyositis. Arthritis Rheum 1990, 33:1640\u20131645.","journal-title":"Arthritis Rheum"},{"key":"89_CR31","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s100670070030","volume":"19","author":"WA Schmidt","year":"2000","unstructured":"Schmidt WA, Wetzel W, Friedlander R, et al.: Clinical and serological aspects of patients with anti-Jo-1 antibodies: an evolving spectrum of disease manifestations. Clin Rheumatol 2000, 19:371\u2013377. This extensive review is helpful in obtaining a broader picture of this syndrome. The study highlighted the interesting observation that the first symptom in a majority of anti-Jo-1 patients is an extramuscular feature.","journal-title":"Clin Rheumatol"},{"key":"89_CR32","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/1529-0131(199808)41:8<1428::AID-ART12>3.0.CO;2-J","volume":"41","author":"R Brouwer","year":"1998","unstructured":"Brouwer R, Vree Egberts W, Jongen PH, et al.: Frequent occurrence of anti-tRNA(His) autoantibodies that recognize a conformational epitope in sera of patients with myositis. Arthritis Rheum 1998, 41:1428\u20131437.","journal-title":"Arthritis Rheum"},{"key":"89_CR33","first-page":"S146","volume":"40","author":"M Hirakata","year":"1997","unstructured":"Hirakata M, Matsuura Y, Suwa A, et al.: Immunological and histopathological features of patients with anti-SRP autoantibodies [abstract]. Arthritis Rheum 1997, 40:S146.","journal-title":"Arthritis Rheum"},{"key":"89_CR34","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/00002281-200111000-00004","volume":"13","author":"GJ Hengstman","year":"2001","unstructured":"Hengstman GJ, van Engelen BG, Vree Egberts WT, van Venrooij WJ: Myositis-specific autoantibodies: overview and recent developments. Curr Opin Rheumatol 2001, 13:476\u2013482.","journal-title":"Curr Opin Rheumatol"},{"key":"89_CR35","first-page":"S403","volume":"42","author":"EA Shamim","year":"1999","unstructured":"Shamim EA, Rider LG, O\u2019Hanlon TP, et al.: Clinical, serologic and genetic differences between U.S. Caucasians and Meso- Americans with idiopathic inflammatory myopathy (IIM) [abstract]. Arthritis Rheum 1999, 42:S403.","journal-title":"Arthritis Rheum"},{"key":"89_CR36","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1002\/art.1780371019","volume":"37","author":"LG Rider","year":"1994","unstructured":"Rider LG, Miller FW, Targoff IN, et al.: A broadened spectrum of juvenile myositis: myositis-specific autoantibodies in children. Arthritis Rheum 1994, 37:1534\u20131538.","journal-title":"Arthritis Rheum"},{"key":"89_CR37","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/art.1780381006","volume":"38","author":"HP Seelig","year":"1995","unstructured":"Seelig HP, Moosbrugger I, Ehrfeld H, et al.: The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation. Arthritis Rheum 1995, 38:1389\u20131399.","journal-title":"Arthritis Rheum"},{"key":"89_CR38","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1172\/JCI118218","volume":"96","author":"Q Ge","year":"1995","unstructured":"Ge Q, Nilasena DS, O\u2019Brien CA, et al.: Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. J Clin Invest 1995, 96:1730\u20131737.","journal-title":"J Clin Invest"},{"key":"89_CR39","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1002\/art.1780391029","volume":"39","author":"HP Seelig","year":"1996","unstructured":"Seelig HP, Renz M, Targoff IN, et al.: Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen. Arthritis Rheum 1996, 39:1769\u20131771.","journal-title":"Arthritis Rheum"},{"key":"89_CR40","doi-asserted-by":"publisher","first-page":"11472","DOI":"10.1073\/pnas.94.21.11472","volume":"94","author":"T Woodage","year":"1997","unstructured":"Woodage T, Basrai MA, Baxevanis AD, et al.: Characterization of the CHD family of proteins. Proc Natl Acad Sci U S A 1997, 94:11472\u201311477.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"89_CR41","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0092-8674(00)81758-4","volume":"95","author":"Y Zhang","year":"1998","unstructured":"Zhang Y, LeRoy G, Seelig HP, et al.: The dermatomyositisspecific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell 1998, 95:279\u2013289.","journal-title":"Cell"},{"key":"89_CR42","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1093\/nar\/29.12.2517","volume":"29","author":"HB Wang","year":"2001","unstructured":"Wang HB, Zhang Y: Mi2, an auto-antigen for dermatomyositis, is an ATP-dependent nucleosome remodeling factor. Nucleic Acids Res 2001, 29:2517\u20132521. Conclusively establishes a role for Mi-2 antigen in nucleosome remodeling.","journal-title":"Nucleic Acids Res"},{"key":"89_CR43","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1101\/gad.13.18.2388","volume":"13","author":"Y Zhang","year":"1999","unstructured":"Zhang Y, Ng HH, Erdjument-Bromage H, et al.: Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 1999, 13:1924\u20131935.","journal-title":"Genes Dev"},{"key":"89_CR44","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/00005792-199211000-00001","volume":"71","author":"C Marguerie","year":"1992","unstructured":"Marguerie C, Bunn CC, Copier J, et al.: The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl. Medicine 1992, 71:327\u2013336.","journal-title":"Medicine"},{"key":"89_CR45","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1002\/art.1780390920","volume":"39","author":"Q Ge","year":"1996","unstructured":"Ge Q, Wu Y, James JA, Targoff IN: Epitope analysis of the major reactive region of the 100-kd protein of PM-Scl autoantigen. Arthritis Rheum 1996, 39:1588\u20131595.","journal-title":"Arthritis Rheum"},{"key":"89_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s001090050381","volume":"78","author":"M Bluthner","year":"2000","unstructured":"Bluthner M, Mahler M, Muller DB, et al.: Identification of an alpha-helical epitope region on the PM\/Scl-100 autoantigen with structural homology to a region on the heterochromatin p25beta autoantigen using immobilized overlapping synthetic peptides. J Mol Med 2000, 78:47\u201354. A major epitope of PM-Scl is analyzed in detail, suggesting a relation to another antigen recognized by some patients with scleroderma.","journal-title":"J Mol Med"},{"key":"89_CR47","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1101\/gad.13.16.2148","volume":"13","author":"C Allmang","year":"1999","unstructured":"Allmang C, Petfalski E, Podtelejnikov A, et al.: The yeast exosome and human PM-Scl are related complexes of 3\u2019 --> 5\u2019 exonucleases. Genes Dev 1999, 13:2148\u20132158. Establishes the PM-Scl antigen complex as the human homologue of the exosome, a complex of exonucleases involved in ribonucleic-acid processing.","journal-title":"Genes Dev"},{"key":"89_CR48","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/ar147","volume":"3","author":"R Brouwer","year":"2001","unstructured":"Brouwer R, Pruijn GJ, van Venrooij WJ: The human exosome: an autoantigenic complex of exoribonucleases in myositis and scleroderma. Arthritis Res 2001, 3:102\u2013106. Helpful description of the PM-Scl antigen complex.","journal-title":"Arthritis Res"},{"key":"89_CR49","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1074\/jbc.M007603200","volume":"276","author":"R Brouwer","year":"2002","unstructured":"Brouwer R, Allmang C, Raijmakers R, et al.: Three novel components of the human exosome. J Biol Chem 2002, 276:6177\u20136184. Further characterization of the PM-Scl antigen.","journal-title":"J Biol Chem"},{"key":"89_CR50","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1136\/jnnp.68.4.472","volume":"68","author":"T Mozaffar","year":"2000","unstructured":"Mozaffar T, Pestronk A: Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres. J Neurol Neurosurg Psychiatry 2000, 68:472\u2013478. This careful analysis of muscle histology in anti-Jo-1-positive myositis demonstrated distinctive features that suggest fundamental differences between this condition and antibody-negative myositis.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"89_CR51","doi-asserted-by":"publisher","first-page":"9209","DOI":"10.1073\/pnas.97.16.9209","volume":"97","author":"K Nagaraju","year":"2000","unstructured":"Nagaraju K, Raben N, Loeffler L, et al.: Conditional upregulation of MHC class I in skeletal muscle leads to selfsustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci U S A 2000, 97:9209\u20139214. Interesting and revealing model that suggests that anti-Jo-1 can appear as a consequence of myositis or of the conditions leading to it, rather than requiring a primary stimulus, such as a virus, directing the immune response to Jo-1 antigen.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"89_CR52","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1084\/jem.190.6.815","volume":"190","author":"L Casciola-Rosen","year":"1999","unstructured":"Casciola-Rosen L, Andrade F, Ulanet D, et al.: Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med 1999, 190:815\u2013826. Evidence is presented for a hypothesis that might explain the myriad cellular proteins targeted by autoantibodies, with several myositis antibodies highlighted.","journal-title":"J Exp Med"},{"key":"89_CR53","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/1529-0131(200102)44:2<389::AID-ANR58>3.0.CO;2-R","volume":"44","author":"LA Casciola-Rosen","year":"2001","unstructured":"Casciola-Rosen LA, Pluta AF, Plotz PH, et al.: The DNA mismatch repair enzyme PMS1 is a myositis-specific autoantigen. Arthritis Rheum 2001, 44:389\u2013396. A new autoantibody associated with myositis, that appears relatively myositis-specific at this point. Although found in less than 10% of patients, the frequency is comparable with several established myositis-associated autoantibodies. The observation of antibodies to other proteins of related function is of particular interest.","journal-title":"Arthritis Rheum"},{"key":"89_CR54","doi-asserted-by":"publisher","first-page":"S191","DOI":"10.1002\/art.1780390203","volume":"39","author":"A Goel","year":"1996","unstructured":"Goel A, Fertig N, Oddis CV, Londino AV: Serum autoantibodies in idiopathic inflammatory myopathy (IIM) of childhood [abstract]. Arthritis Rheum 1996, 39:S191.","journal-title":"Arthritis Rheum"},{"key":"89_CR55","first-page":"S139","volume":"40","author":"CV Oddis","year":"1997","unstructured":"Oddis CV, Fertig N, Goel A, et al.: Clinical and serological characterization of the anti-MJ antibody in childhood myositis [abstract]. Arthritis Rheum 1997, 40:S139.","journal-title":"Arthritis Rheum"},{"key":"89_CR56","doi-asserted-by":"publisher","first-page":"S175","DOI":"10.1002\/1529-0131(200001)43:1<175::AID-ANR22>3.0.CO;2-S","volume":"43","author":"IN Targoff","year":"2000","unstructured":"Targoff IN, Shamim E, Sherry DD, Wallace C, Haftel H, Miller FW, Rider LG, The Childhood Myositis Heterogeneity Study Group, The International Myositis Collaborative Study Group: A novel dermatomyositis (DM)-associated autoantibody directed against a 155 kd protein [abstract]. Arthritis Rheum 2000, 43:S175.","journal-title":"Arthritis Rheum"},{"key":"89_CR57","first-page":"S194","volume":"43","author":"IN Targoff","year":"2000","unstructured":"Targoff IN, Trieu EP, Sontheimer RD: Autoantibodies to 155 kd and Se antigens in patients with clinically-amyopathic dermatomyositis [abstract]. Arthritis Rheum 2000, 43:S194.","journal-title":"Arthritis Rheum"},{"key":"89_CR58","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.4049\/jimmunol.138.8.2463","volume":"138","author":"H Arad-Dann","year":"1987","unstructured":"Arad-Dann H, Isenberg DA, Shoenfeld Y, et al.: Autoantibodies against a specific nuclear RNP protein in sera of patients with autoimmune rheumatic disease associated with myositis. J Immunol 1987, 138:2463\u20132468.","journal-title":"J Immunol"},{"key":"89_CR59","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/0896-8411(89)90014-0","volume":"2","author":"H Arad-Dann","year":"1989","unstructured":"Arad-Dann H, Isenberg D, Ovadia E, et al.: Autoantibodies against a nuclear 56-kDa protein: a marker for inflammatory muscle disease. J Autoimmun 1989, 2:877\u2013888.","journal-title":"J Autoimmun"},{"key":"89_CR60","first-page":"451","volume":"12","author":"G Cambridge","year":"1994","unstructured":"Cambridge G, Ovadia E, Isenberg DA, et al.: Juvenile dermatomyositis: serial studies of circulating autoantibodies to a 56kD nuclear protein. Clin Exp Rheumatol 1994, 12:451\u2013457.","journal-title":"Clin Exp Rheumatol"},{"key":"89_CR61","first-page":"S293","volume":"44","author":"JL Lutz","year":"2001","unstructured":"Lutz JL, Fedczyna TO, Isenberg D, et al.: The association of the DQA1*0501 allele and antibody to a 56 kD nuclear protein in sera from patients with juvenile dermatomyositis (JDM) [abstract]. Arthritis Rheum 2001, 44:S293.","journal-title":"Arthritis Rheum"},{"key":"89_CR62","first-page":"2707","volume":"27","author":"M Kajihara","year":"2000","unstructured":"Kajihara M, Kuwana M, Tokuda H, et al.: Myositis and interstitial lung disease associated with autoantibody to a transfer RNA-related protein Wa. J Rheumatol 2000, 27:2707\u20132710.","journal-title":"J Rheumatol"},{"key":"89_CR63","doi-asserted-by":"publisher","first-page":"9739","DOI":"10.1073\/pnas.89.20.9739","volume":"89","author":"C Gelpi","year":"1992","unstructured":"Gelpi C, Sontheimer EJ, Rodriguez-Sanchez JL: Autoantibodies against a serine tRNA-protein complex implicated in cotranslational selenocysteine insertion. Proc Natl Acad Sci U S A 1992, 89:9739\u20139743.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"89_CR64","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/rheumatology\/40.10.1157","volume":"40","author":"VJ Tormey","year":"2001","unstructured":"Tormey VJ, Bunn CC, Denton CP, Black CM: Anti-fibrillarin antibodies in systemic sclerosis. Rheumatology 2001, 40:1157\u20131162. Confirms the observation of Okano et al. (Arthritis Rheum 1992, 35:95-100) that patients with scleroderma and this antibody have an increased frequency of muscle involvement.","journal-title":"Rheumatology"},{"key":"89_CR65","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1006\/jaut.1998.0265","volume":"12","author":"MB Frank","year":"1999","unstructured":"Frank MB, McCubbin VR, Trieu EP, et al.: The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies. J Autoimmun 1999, 12:137\u2013142.","journal-title":"J Autoimmun"},{"key":"89_CR66","first-page":"161","volume":"27","author":"D D\u2019Cruz","year":"2000","unstructured":"D\u2019Cruz D, Keser G, Khamashta MA, et al.: Antiendothelial cell antibodies in inflammatory myopathies: distribution among clinical and serologic groups and association with interstitial lung disease. J Rheumatol 2000, 27:161\u2013164.","journal-title":"J Rheumatol"},{"key":"89_CR67","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1046\/j.1523-1747.1999.00580.x","volume":"112","author":"M Kubo","year":"1999","unstructured":"Kubo M, Ihn H, Yazawa N, et al.: Prevalence and antigen specificity of anti-histone antibodies in patients with polymyositis\/ dermatomyositis. J Invest Dermatol 1999, 112:711\u2013715.","journal-title":"J Invest Dermatol"},{"key":"89_CR68","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1084\/jem.184.4.1313","volume":"184","author":"E Feist","year":"1996","unstructured":"Feist E, Dorner T, Kuckelkorn U, et al.: Proteasome alpha-type subunit C9 is a primary target of autoantibodies in sera of patients with myositis and systemic lupus erythematosus. J Exp Med 1996, 184:1313\u20131318.","journal-title":"J Exp Med"},{"key":"89_CR69","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/1529-0131(199904)42:4<697::AID-ANR12>3.0.CO;2-H","volume":"42","author":"E Feist","year":"1999","unstructured":"Feist E, Kuckelkorn U, Dorner T, et al.: Autoantibodies in primary Sj\u00f6gren\u2019s syndrome are directed against proteasomal subunits of the alpha and beta type. Arthritis Rheum 1999, 42:697\u2013702.","journal-title":"Arthritis Rheum"},{"key":"89_CR70","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/00002281-199711000-00008","volume":"9","author":"IN Targoff","year":"1997","unstructured":"Targoff IN, Miller FW, Medsger TA Jr, Oddis CV: Classification criteria for the idiopathic inflammatory myopathies. Curr Opin Rheumatol 1997, 9:527\u2013535.","journal-title":"Curr Opin Rheumatol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-002-0089-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-002-0089-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-002-0089-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-002-0089-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:32:35Z","timestamp":1744165955000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-002-0089-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["89"],"URL":"https:\/\/doi.org\/10.1007\/s11926-002-0089-7","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}